Browse drugs

…tational age was 37.7 weeks (SD 4.7). During pregnancy 68% used hydroxychloroquine (HCQ) in monotherapy, 23% used a combination of HCQ and azathio…

…dysregulated pathways and corresponding therapies. For example, BAFF inhibition showed high response proportions within interferon-a…

…ids(CS) and 18% received IVIg(17 in combination with CS, 1 with IVIg alone). Early response within the first month was observed in 9…

…ntation in 2014, he was on hydroxychloroquine, methotrexate and coumadin with a therapeutic INR. His testicular Doppler ultrasound was s…

…ower levels of disease activity supports benefits of initiating belimumab treatment earlier in the disease course. Funding: GSK, Original…

…ty index was 6.4 (SD 5.4) and the chronicity index 2.6 (SD 2.5).Voclosporin was used as initial therapy for active LN in 7 cases, as rescue…

…atment responses, and safety outcomes of SLE patients receiving anifrolumab in routine clinical practice. We retrospectively reviewed 7 fem…

…o investigate DORIS remission attainment following subcutaneous anifrolumab initiation among patients with SLE who are naïve to conventiona…

…eater extent in SRI-4 responders vs non-responders ( figure 1). Cenerimod 2 mg showed less pronounced effects; placebo showed minimal cha…

….87 for distinguishing progression patterns ( figure 1). In the atorvastatin arm, a distinct autoantibody profile comprising eight autoantib…

…48.2 years), 72% reported being PASS-A. Lower disease activity (SLEDAI-2K OR 0.95, 95% CI 0.92–0.99), DORIS remission (OR 2.48, 95% CI 1.…

…Objectives In this study, we aimed to investigate serum suPAR levels in relation to lupus nephritis (LN), including activity …